Müther, M.* et al. P07.21.A A PHASE I TRIAL TO DETERMINE THE MAXIMUM TOLERATED DOSE AND PATIENT-SPECIFIC DOSIMETRY OF FRACTIONATED INTRACAVITARY RADIOIMMUNOTHERAPY WITH LUTETIUM-177 LABELED 6A10 FAB FRAGMENTS IN PATIENTS WITH GLIOBLASTOMA - PRELIMINARY RESULTS FROM THE FIRST PATIENT COHORT. Neuro. Oncol. 27, iii81 - iii82 (2025)
Ruiz-Moreno, C.* et al. Charting the single-cell and spatial landscape of IDH-wildtype glioblastoma with GBmap. Neuro. Oncol., 15 (2025)
Buchner, J.A.* et al. Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy. Neuro. Oncol. 26, 1638-1650 (2024)
Kurz, S.C.* et al. Towards more Diversity in Neuro-oncology Leadership-the DivINe Initiative. Neuro. Oncol. 25, 2302-2304 (2023)
Kebir, S.* et al. Gender disparity regarding work-life balance satisfaction among German neuro-oncologists: A YoungNOA survey. Neuro. Oncol. 24, 1609-1611 (2022)
Volmar, M.N.M.* et al. Cannabidiol converts NFκB into a tumor suppressor in glioblastoma with defined antioxidative properties. Neuro. Oncol. 23, 1898-1910 (2021)
Bernhardt, D. et al. Neuro-oncology managment during the COVID-19 pandemic with a focus on WHO grade III and IV gliomas. Neuro. Oncol. 22, 928-935 (2020)
Bernhardt, D. & Combs, S.E. Reply to: Call of duty: Neuro-oncology outpatient management during the COVID-19 pandemic in Milan, ITALY. Neuro. Oncol. 22:1893 (2020)
Sbiera, S.* et al. Driver mutations in USP8 wild-type Cushing's disease. Neuro. Oncol. 21, 1273-1283 (2019)
Volmar, M.* et al. RelA-activity is essential for cannabidiol-mediated cytotoxicity in an identified subset of glioblastoma. Neuro. Oncol. 21, 70-71 (2019)
Andor, N.* et al. Clonal expansions and evolving subpopulations in glioblastoma multiforme. Neuro. Oncol. 15, 136-137 (2013)
Schäfer, A.* et al. Aldehyde dehydrogenase 1A1 - a new mediator of resistance to temozolomide in glioblastoma. Neuro. Oncol. 14, 1452-1464 (2012)
Rasper, M.* et al. Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity. Neuro. Oncol. 12, 1024-1033 (2010)